Article
Association study of genetic polymorphisms in proteins involved in oseltamivir transport, metabolism, and interactions with adverse reactions in Mexican patients with acute respiratory diseases.
The pharmacogenomics journal - 1 Aug 2020
Bermúdez de León Mario, León-Cachón Rafael B R, Silva-Ramírez Beatriz, González-Ríos Rosa Nelly, Escobedo-Guajardo Brenda, Leyva-Parra Roberto, Tovar-Cisneros Benjamín, González-González Everardo, Alvarado-Díaz Abdiel, Vázquez-Monsiváis Ofelia, Mata-Tijerina Viviana, Puente-Lugo Lorena, Álvarez-Galván Erick, Currás-Tuala María José, Aguado-Barrera Miguel, Castorena-Torres Fabiola, Alcocer-González Juan Manuel, Elizondo Guillermo, Salinas-Martínez Ana María
Abstract excerpt
Oseltamivir, a pro-drug, is the best option for treatment and chemoprophylaxis for influenza outbreaks. However, many patients treated with oseltamivir developed adverse reactions, including hypersensitivity, gastritis, and neurological symptoms. The aim of this study was to determine the adverse drug reactions (ADRs) in Mexican patients treated with oseltamivir and whether these ADRs are associated with SNPs of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
